CIN3 involving the glandular tissue

The cervix is a vital reproductive organ in women—and one highly susceptible to pathological changes. Some of these changes are of intermediate or precancerous nature, such as cervical intraepithelial neoplasia (CIN). CIN is the English abbreviation for cervical intraepithelial neoplasia. During routine gynecological examinations, some women receive a diagnosis of “CIN3 with glandular involvement,” leaving them uncertain about its clinical significance. So, what exactly does “CIN3 with glandular involvement” mean? Below, we provide a clear explanation.

What Does “CIN3 with Glandular Involvement” Mean?

CIN stands for cervical intraepithelial neoplasia—a precancerous condition of the cervix. Based on histopathological criteria, CIN is classified into three grades (CIN1, CIN2, and CIN3). Untreated CIN2 or CIN3 may progress to invasive cervical cancer. “CIN3 with glandular involvement” is a descriptive histopathological term; clinically, its management is essentially identical to that of standard CIN3. If left untreated, both CIN3 and CIN3 with glandular involvement may progress further—breaking through the basement membrane beneath the epithelium and invading the underlying stroma—thereby developing into invasive cervical carcinoma. Therefore, both conditions require definitive treatment.

For patients with adequate colposcopic evaluation, cervical conization is recommended—including cold-knife conization (CKC) and loop electrosurgical excision procedure (LEEP). Following conization, if invasive cervical cancer is definitively ruled out pathologically, and the patient is older, has no desire for future childbearing, and/or has coexisting benign gynecologic conditions, a total hysterectomy (extrafascial) may be indicated. Conversely, younger patients—even those desiring future fertility—may undergo close surveillance after conization, provided they meet appropriate follow-up criteria.

Knowledge Extension: How to Prevent Cervical Cancer

1. HPV Vaccination

Globally, two prophylactic vaccines against cervical cancer have been approved and implemented clinically in numerous countries. Experts recommend that the optimal candidates for vaccination are young women who have not yet initiated sexual activity. Moreover, women at higher risk for cervical cancer—including those with histories of early sexual debut or prior induced abortions—stand to benefit significantly from vaccination. Women who are already sexually active should undergo regular gynecologic screening, which plays a critical role in the early detection of cervical cancer.

2. Regular Screening

Pap smear—or cervical cytology—is the oldest and most established method for cervical cancer prevention. It involves collecting a small sample of cells from the cervical surface, smearing them onto a glass slide, and examining them microscopically for abnormal or precancerous changes. Combining HPV testing with cytology significantly enhances the detection rate of early cervical lesions. When both HPV testing and cytology yield normal results, the short-term risk of developing cervical disease is considered very low.

The above provides an overview of the meaning and implications of “CIN3 with glandular involvement.” We hope this information is helpful to you.